<SEC-DOCUMENT>0000093751-26-000197.txt : 20260512
<SEC-HEADER>0000093751-26-000197.hdr.sgml : 20260512
<ACCEPTANCE-DATETIME>20260512094212
ACCESSION NUMBER:		0000093751-26-000197
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260512
DATE AS OF CHANGE:		20260512

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			4D Molecular Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001650648
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473506994
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91921
		FILM NUMBER:		26966267

	BUSINESS ADDRESS:	
		STREET 1:		5858 HORTON STREET #455
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5105052680

	MAIL ADDRESS:	
		STREET 1:		5858 HORTON STREET #455
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	4D Molecular Therapeutics Inc.
		DATE OF NAME CHANGE:	20200506

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	4D Molecular Therapeutics Inc
		DATE OF NAME CHANGE:	20150811

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STATE STREET CORP
		CENTRAL INDEX KEY:			0000093751
		STANDARD INDUSTRIAL CLASSIFICATION:	STATE COMMERCIAL BANKS [6022]
		ORGANIZATION NAME:           	02 Finance
		EIN:				042456637
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		1 CONGRESS STREET
		STREET 2:		SUITE 1
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02114
		BUSINESS PHONE:		617 786-3000

	MAIL ADDRESS:	
		STREET 1:		1 CONGRESS STREET
		STREET 2:		SUITE 1
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STATE STREET Corp
		DATE OF NAME CHANGE:	20090218

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STATE STREET CORP
		DATE OF NAME CHANGE:	19970424

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STATE STREET BOSTON FINANCIAL CORP
		DATE OF NAME CHANGE:	19780525
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
   <schemaVersion>X0202</schemaVersion>
<headerData>
      <submissionType>SCHEDULE 13G</submissionType>
      <filerInfo>
         <filer>
            <filerCredentials>
               <cik>0000093751</cik>
               <ccc>XXXXXXXX</ccc>
            </filerCredentials>
         </filer>
         <liveTestFlag>LIVE</liveTestFlag>



      </filerInfo>
   </headerData>
   <formData>
      <coverPageHeader>
         <securitiesClassTitle>COMMON STOCK</securitiesClassTitle>
         <eventDateRequiresFilingThisStatement>03/31/2026</eventDateRequiresFilingThisStatement>
         <issuerInfo>
            <issuerCik>0001650648</issuerCik>
            <issuerName>4D MOLECULAR THERAPEUTICS INC</issuerName>
            <issuerCusips>
               <issuerCusipNumber>35104E100</issuerCusipNumber>
            </issuerCusips>
            <issuerPrincipalExecutiveOfficeAddress>
               <com:street1>5858 HORTON STREET SUITE 455</com:street1>
               <com:city>EMERYVILLE</com:city>
               <com:stateOrCountry>CA</com:stateOrCountry>
               <com:zipCode>94608</com:zipCode>
            </issuerPrincipalExecutiveOfficeAddress>
         </issuerInfo>
         <designateRulesPursuantThisScheduleFiled>
            <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
         </designateRulesPursuantThisScheduleFiled>
      </coverPageHeader>
      <coverPageHeaderReportingPersonDetails>


         <reportingPersonName>STATE STREET CORPORATION</reportingPersonName>
         <citizenshipOrOrganization>MA</citizenshipOrOrganization>
         <reportingPersonBeneficiallyOwnedNumberOfShares>
            <soleVotingPower>0.00</soleVotingPower>
            <sharedVotingPower>2647452.00</sharedVotingPower>
            <soleDispositivePower>0.00</soleDispositivePower>
            <sharedDispositivePower>2707875.00</sharedDispositivePower>
         </reportingPersonBeneficiallyOwnedNumberOfShares>
         <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2707875.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
         <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
         <classPercent>5.3</classPercent>
         <typeOfReportingPerson>HC</typeOfReportingPerson>
      </coverPageHeaderReportingPersonDetails>
      <items>
         <item1>
            <issuerName>4D MOLECULAR THERAPEUTICS INC</issuerName>
            <issuerPrincipalExecutiveOfficeAddress>5858 HORTON STREET SUITE 455, EMERYVILLE, CALIFORNIA, 94608</issuerPrincipalExecutiveOfficeAddress>
         </item1>
         <item2>
            <filingPersonName>STATE STREET CORPORATION;</filingPersonName>
            <principalBusinessOfficeOrResidenceAddress>ONE CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES</principalBusinessOfficeOrResidenceAddress>
            <citizenship>MA</citizenship>
         </item2>
         <item3>
            <notApplicableFlag>N</notApplicableFlag>
            <typeOfPersonFiling>IA</typeOfPersonFiling>
            <typeOfPersonFiling>HC</typeOfPersonFiling>
         </item3>
         <item4>
            <amountBeneficiallyOwned>2707875.00</amountBeneficiallyOwned>
            <classPercent>5.3</classPercent>
            <numberOfSharesPersonHas>
               <solePowerOrDirectToVote>0</solePowerOrDirectToVote>
               <sharedPowerOrDirectToVote>2,647,452</sharedPowerOrDirectToVote>
               <solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
               <sharedPowerOrDirectToDispose>2,707,875</sharedPowerOrDirectToDispose>
            </numberOfSharesPersonHas>
         </item4>
         <item5>
            <notApplicableFlag>Y</notApplicableFlag>
            <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
         </item5>
         <item6>
            <notApplicableFlag>N</notApplicableFlag>
            <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>NOT APPLICABLE</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
         </item6>
         <item7>
            <notApplicableFlag>N</notApplicableFlag>
            <subsidiaryIdentificationAndClassification>SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);</subsidiaryIdentificationAndClassification>
         </item7>
         <item8>
            <notApplicableFlag>N</notApplicableFlag>
            <identificationAndClassificationOfGroupMembers>NOT APPLICABLE</identificationAndClassificationOfGroupMembers>
         </item8>
         <item9>
            <notApplicableFlag>N</notApplicableFlag>
            <groupDissolutionNotice>NOT APPLICABLE</groupDissolutionNotice>
         </item9>
         <item10>
            <notApplicableFlag>N</notApplicableFlag>
            <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
         </item10>
      </items>
      <signatureInformation>
         <reportingPersonName>STATE STREET CORPORATION</reportingPersonName>
         <signatureDetails>
            <signature>ELIZABETH SCHAEFER</signature>
            <title>SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER</title>
            <date>05/12/2026</date>
         </signatureDetails>
      </signatureInformation>
   </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
